Cited 0 times in

췌장암의 2차 항암치료

Title
췌장암의 2차 항암치료
Other Titles
Second Line Chemotherapy for Pancreatic Cancer
Authors
박정엽
Issue Date
2011
Journal Title
Korean Journal of Gastroenterology (대한소화기학회지)
ISSN
1598-9992
Citation
Korean Journal of Gastroenterology (대한소화기학회지), Vol.57(4) : 207~212, 2011
Abstract
Pancreatic cancer is a very lethal cancer. It is the 5th most common cause for cancer related mortality in Korea. Most of patients have unresectable pancreatic cancer, and systemic chemotherapy remains the only treatment option for them. Gemcitabine has been adopted as the standard first-line agent for advanced pancreatic cancer, but the progression free survival with gemcitabine is short. Many of patients need further treatment. We reviewed the clinical trials of second line chemotherapy for gemcitabine refractory pancreatic cancer and tried to show currently available treatment options
URI
http://kiss.kstudy.com/journal/thesis_name.asp?tname=kiss2002&key=2904944

http://ir.ymlib.yonsei.ac.kr/handle/22282913/93037
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Internal Medicine
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse